// App-Quantinova.ai

2796 : Expanding Use of a Modified Pediatric Intensive Regimen for Acute Lymphoblastic Leukemia (ALL) into an Older Adult Population: Feasibility and Efficacy Results

Researchers

Presenter

  • Anand Ashwin Patel

Principal Investigators

  • Joseph Heng

  • Emily Dworkin

  • Sarah Monick

  • Benjamin A Derman

  • Sandeep Gurbuxani

  • Satyajit Kosuri

  • Hongtao Liu

  • Michael Thirman

  • Lucy A. Godley

  • Olatoyosi Odenike

  • Richard A. Larson

  • Wendy Stock

Medical Centers

  • Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL

  • Department of Radiology, University of Chicago, Chicago, IL

  • The University of Chicago Medical Center, Chicago, IL

  • Department of Radiology, University of Chicago, Chicago, IL

  • Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL

  • Department of Medicine, Univ. of Chicago Med. Ctr., Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Nonalcoholic fatty liver disease

  • Acute lymphoblastic leukemia

  • Fatty Liver Disease

  • Diabetes

  • Cirrhosis

Biomarkers

  • B-lymphocyte antigen CD20

  • Breakpoint Cluster Region

  • Body mass index

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Rituximab

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A